CERo Therapeutics Inc. (CERO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CERo Therapeutics Inc.

    NASDAQ: CERO · Real-Time Price · USD
    5.38
    0.00 (0.00%)
    At close: Sep 26, 2025, 3:59 PM
    5.02
    -6.69%
    After-hours: Sep 26, 2025, 07:55 PM EDT

    CERo Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.16M 1.12M n/a n/a
    Gross Profit
    		 -1.16M -1.12M n/a n/a
    Operating Income
    		 -15.3M -2.93M -2.91M -332.03K
    Interest Income
    		 26.65K 138.34K 2.84M 986.71K
    Pretax Income
    		 -7.73M -2.44M -68.58K -332.42K
    Net Income
    		 -7.73M -2.54K -667.74K -315.55K
    Selling & General & Admin
    		 8.98M 2.89M 2.84M 2.48M
    Research & Development
    		 6.32M n/a 9.85M 9.14M
    Other Expenses
    		 351.00 40.05K -9.78M -11.18M
    Operating Expenses
    		 15.3M 2.93M 2.91M 431.5K
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 2.89M 715.76K -2.23M
    Cost & Expenses
    		 15.3M 2.93M 2.91M 332.03K
    Income Tax Expense
    		 n/a 94.82K 599.16K -16.87K
    Shares Outstanding (Basic)
    		 1.21M 2.92K 33.84K 114.9K
    Shares Outstanding (Diluted)
    		 1.21M 2.92K 33.84K 114.9K
    EPS (Basic)
    		 -6.87 -2.5K -19.73 -2.75
    EPS (Diluted)
    		 -6.87 -2.5K -19.73 -2.75
    EBITDA
    		 -6.57M -2.44M -68.58K -332.03K
    EBIT
    		 -7.73M -2.44M -2.91M -332.42K
    Depreciation & Amortization
    		 1.16M 2.93K 2.91M 735.47K

    Add to Watchlist